"Radiotherapy, High-Energy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, High-Energy".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, High-Energy".
This graph shows the total number of publications written about "Radiotherapy, High-Energy" by people in this website by year, and whether "Radiotherapy, High-Energy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Radiotherapy, High-Energy" by people in Profiles.
Lin L, Kang M, Solberg TD, Mertens T, Baeumer C, Ainsley CG, McDonough JE. Use of a novel two-dimensional ionization chamber array for pencil beam scanning proton therapy beam quality assurance. J Appl Clin Med Phys. 2015 May 08; 16(3):5323.
Ainsley CG, Yeager CM. Practical considerations in the calibration of CT scanners for proton therapy. J Appl Clin Med Phys. 2014 May 08; 15(3):4721.
Lin L, Shen J, Ainsley CG, Solberg TD, McDonough JE. Implementation of an improved dose-per-MU model for double-scattered proton beams to address interbeamline modulation width variability. J Appl Clin Med Phys. 2014 May 08; 15(3):4748.
Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology. 2009 Mar; 116(3):544-551.e1.
Avery S, Ainsley C, Maughan R, McDonough J. Analytical shielding calculations for a proton therapy facility. Radiat Prot Dosimetry. 2008; 131(2):167-79.
Mahajan A, Shields CL, Eagle RC, Mashayekhi A, Freire JE, Shields JA. Conjunctival melanoma 3 years after radiation and chemotherapy for retinoblastoma. J Pediatr Ophthalmol Strabismus. 2007 Sep-Oct; 44(5):300-2.
Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. Am J Clin Oncol. 2006 Oct; 29(5):435-41.
Chen Y, Hou Q, Galvin JM. A graph-searching method for MLC leaf sequencing under constraints. Med Phys. 2004 Jun; 31(6):1504-11.
Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol. 2003 Aug; 26(4):422-8.
Demirci H, Shields CL, Chao AN, Shields JA. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003 Aug; 136(2):264-71.